Latest Updates

IQVIA Biotech develops and delivers flexible, integrated clinical and commercial solutions designed specifically for early-stage…

The screening camps will focus on prevalent cancers such as oral, cervical and breast

Revenue for the nine months ended December 31, 2018, came in at ₹ 2377 crores

Leaders and experts of the Indian pharma industry to come together and discuss on the  theme, 'Acing the value chain: Leveraging…

Solara proposed to utilise the proceeds for setting up a large-scale greenfield manufacturing facility and cater for future growth…

Ink partnership for capacity building of healthcare personnel Launch the KiDS project to raise awareness amongst next generation…

The short supply represents a missed opportunity for Teva to compete with Mylan in a roughly $750 million a year US market Many…

During 9M’FY19, the consolidated revenue was at ₹ 6,725 crore

Long-term use of prescription opioids for the treatment of chronic pain carries the risk of dependence and other serious harms

The tablets would be generic equivalents to Imbruvica tablets